Member Info for platoh

vodafone is not some ****y little aim share. while doubling is theoretically possible, it’s not going to happen without some material event.

Oops . I foolishly assumed Google would serve me a recent news item as first search result.

Was looking for a reason for the recent increased interest.

Https://uk.news.yahoo.com/finance/news/tissue-regenix-jumps-acl-treatment-150700445.html

Shares in Tissue Regenix jumped on Tuesday, after the producer of devices for regenerative medicine said it had taken a "critical step" towards securing approval for a new treatment. The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has given the green light to the first stage of clinical trials on the company's Orthopure XT

+10% a week for a few weeks would be quite acceptable

Richard Sneller was buying up until end of February, and Lombard Odier has been increasing their stake (up 0.45% in April), as far as I can see.

The share price will move up when PIs see a reason to buy in - maybe at the next trading update (mid July?).

Maybe I missed something, but I don't recall, nor can I find, any communications giving the resolutions at the AGM. The TRX website doesn't show anything that I can find, only AGMs up to 2023. Nothing on my dealing site either.

Has anyone received/seen anything? I'd like to know what the resolutions are (I'd like to have had an opportunity to vote on them!).

And on the subject of the company web site, if anyone from TRX is reading this, please bring it up to date.

Good to see Lombard Odier steadily increasing their stake: 10.01% last year, 10.75% in February, now 11.03%

Just now, I'd rate them a buy. It's a very thinly traded stock, and the share price always drops after results as the short term traders unload their speculative holdings. It'll drift up again in the coming months to a new high prior to the next trading update in July. Thereafter, falling back again - unless, of course, there's some really good news in the update, in which case you'd kick yourself for having sold too early :-)

If you do spot a high again, please let us all know before it passes ;-)

1. Markets are down generally

2. Before the last trading update in January, the shares were trading at 51p. Since then they've risen 30%. People who bought in then will have been taking profits.

3. The results only confirmed what was in the trading update, no positive surprises to galvanise buying.

4. The institutional shareholding is pretty static. This share will move when new PIs get interested, which won't be until they read positive news. Too early for that today.

As after the TU, I'd expect a gradual rise over the next couple of weeks, once short-term traders have taken their profits.

Last chance to buy at these low, low prices :-)

Obviously competitive links not allowed. Easy to find on cavendish dot com though.

https://*********************/companies/uk/medical-equipment-services/tissue-regenix-group-plc/research/cavendish/tissue-regenix-record-revenues-and-profitability/129_ca6da6df-6d71-41c1-9616-757b9ff7b3e4

amusingly labelled "prepared solely for jim rabe. not to be distributed anywhere." ;-)

Also good to see SGA costs as a percentage of revenue falling year on year

I feel like Schrödinger’s investor. I am either a happy bunny or a disappointed rabbit. I’ll know tomorrow when they open the results box.

The finals should confirm the good news from the interims, and hopefully report more progress. The notice of results should excite some interest in and demand for the shares amongst PIs, so I'm expecting another run up in the next couple of weeks.

Bought some more this morning on that basis.

It's good to see the share price rising above 60p, but the intra-day high for the last year is still the 70p it reached on 31st March 2023. I won't feel confident in the short term until it steadies in the 70s and I can see a likelihood of further rises after the annual results. At the moment it is still a very thin market.

If they get taken over now, shareholders get a 50%-70% premium to today’s depressed share price. No thank you, this company will be worth more.

No negative surprises. If there are, the SP will tank.

They've consistently said they expect to fund expansion with current capital base, so I hope no rights issue, and would rather see debt fall over next couple of years.

No bad surprises in the trading update and the SP should see a significant improvement from next month.

@jimjam Why should it become clearer in January? Results not before March, surely. Have I missed something?